Low-Cost Insulin from Crops in Three Years?

Sembiosys Genetics (Calgary, AB) says it is on track to launch insulin produced from genetically modified (GM) plants within three years. The company says it has made significant scientific breakthroughs in recent months and identified a “short cut” through existing drug regulations. Sembiosys has engineered a GM safflower that produces insulin, identical to synthetically produced insulin but at a significantly lower cost, the company says (CW, Jan. 24, p. 35). One large farm producing the newly developed insulin could satisfy global insulin demand...

This information is only available to Chemical Week subscribers.

Forgot your user ID or password?
Click here to have it sent to you.

Email Address First Name Last Name

Not an IHS Chemical Week 24/7 member yet? Here's why you should be: Searchable online archive access of the last 2 years of Chemical Week. Print or digital magazine subscription Price and market change alerts Economic data and statistics Buyers' Guides Webcasts | whitepapers